EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieOpen Access · CC BY 4.0

Community-based analysis of stroke prevention and effect of public interventions in atrial fibrillation: results from the ARENA project

Maura M Zylla, Belgin Özdemir, Matthias Hochadel, U Zeymer, Ibrahim Akin, Armin Grau, Steffen Schneider, Angelika Alonso, Bernd Waldecker, Tim Süselbeck, Harald Schwacke, Markus Haass und 5 weitere

Clinical Research in Cardiology · 2025

DOI: 10.1007/s00392-024-02510-6 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical Research in Cardiology, 2025. Verfasst von Maura M Zylla und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University of Heidelberg, Medical University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany. maura.zylla@med…. Hauptthemen laut MEDLINE: Anticoagulants, Atrial Fibrillation, Quality of Life, Stroke. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Boehringer Ingelheim, Stiftung Institut für Herzinfarktforschung, Deutsche Stiftung für Herzforschung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Community-based interventions may promote awareness and adherence to atrial fibrillation (AF)-related therapies, potentially reducing adverse events. The ARENA project investigated the health status, therapies and events in AF patients in the Rhein–Neckar Region, Germany. The subproject “ARENA intervention” studied the effect of community-based interventions on AF-associated outcomes.

Methods

From 2016 onward, patients with diagnosed AF were recruited for the observational ARENA registry. In 2018, an intervention period was initiated involving population-based information campaigns on AF diagnosis and therapies. The “control group” was recruited prior to initiation, and the “intervention group” afterward. Patients underwent standardized follow-up > 1 year after recruitment. Clinical outcomes, therapy and quality of life were compared between the two groups.

Results

A total of 2769 patients were included. This real-world cohort showed high adherence to oral anticoagulation therapy (OAC) and an increased use of NOACs over vitamin K antagonists over time. In the intervention group ( n = 1362), more patients continued OAC at follow-up (87.1% vs. 81.5%, P = 0.002). However, this difference was not significant in the patient subgroup with class I/IIa indications for OAC (90.1% vs. 87.5%, P = 0.11). AF-related re-hospitalization was lower in the intervention group (6.8% vs. 12.3%, P < 0.001). There was no significant difference in quality of life. AF-related anxiety was reduced at follow-up. Of note, nearly a quarter of all patients stated that ARENA had influenced their health perception.

Conclusion

Tailored community-based campaigns may raise awareness for AF-related health issues, supporting therapy adherence. Future public strategies to improve quality of life in AF patients should be investigated, as the ARENA project hints at a potential benefit of population-based campaigns.

Trial registration

ClinicalTrials.gov (Identifier: NCT02978248).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticoagulantsAtrial FibrillationQuality of LifeStrokeAgedAged, 80 and overFemaleHumansMaleMiddle AgedFollow-Up StudiesGermanyRegistries

Stichwörter der Autor:innen

Atrial fibrillationCommunity-based interventionOral anticoagulationPatient-reported outcomesQuality of life

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Department of Cardiology, University of Heidelberg, Medical University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany. maura.zylla@med.uni-heidelberg.de.
  • HCR (Heidelberg Center for Heart Rhythm Disorders), Medical University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany. maura.zylla@med.uni-heidelberg.de.
  • DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany. maura.zylla@med.uni-heidelberg.de.
  • Stiftung Institut für Herzinfarktforschung, IHF, Bremserstraße 79, 67063, Ludwigshafen, Germany.
  • Department of Cardiology, Hospital Ludwigshafen, Bremserstraße 79, 67063, Ludwigshafen, Germany.
  • DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany.

Förderung

  • Boehringer Ingelheim
  • Stiftung Institut für Herzinfarktforschung
  • Deutsche Stiftung für Herzforschung
  • Universitätsklinikum Heidelberg

Zitieren

APA

Zylla, M. M., Özdemir, B., Hochadel, M., Zeymer, U., Akin, I., Grau, A., Schneider, S., Alonso, A., Waldecker, B., Süselbeck, T., Schwacke, H., Haass, M., Zahn, R., Borggrefe, M., Senges, J., Frey, N., & Thomas, D. (2025). Community-based analysis of stroke prevention and effect of public interventions in atrial fibrillation: results from the ARENA project. Clinical Research in Cardiology. https://doi.org/10.1007/s00392-024-02510-6

Vancouver

Zylla MM, Özdemir B, Hochadel M, Zeymer U, Akin I, Grau A, et al. Community-based analysis of stroke prevention and effect of public interventions in atrial fibrillation: results from the ARENA project. Clinical Research in Cardiology. 2025. doi:10.1007/s00392-024-02510-6

BibTeX
@article{Zylla2025,
  author = {Zylla, Maura M and Özdemir, Belgin and Hochadel, Matthias and Zeymer, U and Akin, Ibrahim and Grau, Armin and Schneider, Steffen and Alonso, Angelika and Waldecker, Bernd and Süselbeck, Tim and Schwacke, Harald and Haass, Markus and Zahn, Ralf and Borggrefe, Martin and Senges, Jochen and Frey, Norbert and Thomas, Dierk},
  title = {Community-based analysis of stroke prevention and effect of public interventions in atrial fibrillation: results from the ARENA project},
  journal = {Clinical Research in Cardiology},
  year = {2025},
  doi = {10.1007/s00392-024-02510-6}
}
Kostenlos starten →